focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMED.L Regulatory News (MED)

  • There is currently no data for MED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ScanTrainer at Central Middlesex Hospital

7 Jun 2018 07:00

RNS Number : 5559Q
Medaphor Group PLC
07 June 2018
 

 

7 June 2018

MedaPhor Group plc 

("MedaPhor" or the "Group" or the "Company") 

 

ScanTrainer installed at Central Middlesex Hospital

 

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that ScanTrainer, the OBGYN and General Medical simulator training platform, has been installed at a new Ultrasound Training Academy at Central Middlesex Hospital, London, UK.

 

The London North West Healthcare NHS Trust (LNWH) has chosen ScanTrainer for its new state-of-the-art ultrasound education facility based at Central Middlesex Hospital. The Academy has been designed to ease growing ultrasound training pressures and clinical demands across the Trust and beyond.

 

Following an assessment of the ultrasound simulation market, the Trust purchased a ScanTrainer Transvaginal Simulator (TVS) and a ScanTrainer Transabdominal Simulator (TAS) to support the Trust in making training more accessible for those learning and improving their ultrasound skills.

 

Tanuja Khiroya, Clinical Lead Radiology & Medical Physics, at Central Middlesex Hospital, who pioneered and led the project, commented: "Historically ultrasound trainees would have completed the bulk of their learning in the clinic or by using text books. ScanTrainer represents a step-change by enabling clinicians to learn independently in a patient-safe environment before practising on patients. This ensures that trainees are not only acquiring skills faster but are well equipped and confident when it comes to scanning real patients for the first time." 

 

Ian Whittaker, Chief Operating Officer, at MedaPhor, said: "We have seen the emergence of a number of ultrasound academies across the UK recently with Norwich, Leeds, Peninsula, Wales and, of course, Central Middlesex being some of the pioneers in this space. It's very encouraging to see ultrasound skills initiatives such as these taking strides to close the skills gap and MedaPhor is delighted to be able to equip them with simulation technologies that can help them achieve their goals."

 

 

MedaPhor Group plc 

www.medaphor.com 

Stuart Gall, CEO 

Ian Whittaker, COO

Tel: +44 (0)29 2075 6534 

Cenkos Securities 

Tel: +44 (0)20 7397 8900 

Camilla Hume (Nominated Advisor) 

Michael Johnson / Julian Morse (Corporate Broking) 

Walbrook PR 

Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com 

Paul McManus / Anna Dunphy 

Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001 

 

 

 

 

 

 

 

 

 

 

About MedaPhor (www.investors.medaphor.com)

 

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops artificial intelligence-based clinical image analysis software tools, augmented reality-based needle guidance software and advanced hi-fidelity haptic and manikin-based training simulators for medical practitioners.

 

Based in Cardiff and Oxford in the UK, Atlanta in the US and Hong Kong in Asia, MedaPhor operates two divisions:

 

Intelligent Ultrasound Simulation Division 

Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks echocardiography simulator platform and the BodyWorks Eve Point of Care and Emergency Medicine Simulator. Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

 

Intelligent Ultrasound Clinical Division 

Focuses on augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav and NeedleGuide. ScanNav uses machine-learning based algorithms to automatically identify, grade and capture good ultrasound images. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

 

Some products in the pipeline may require US FDA approval, as such this material should be considered informational only and does not constitute an offer to sell or infer claims or benefits.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEASKKEDSPEFF
Date   Source Headline
17th Dec 20207:00 amRNSChange of ticker
2nd Dec 20207:00 amRNSChange of auditor
30th Oct 20207:00 amRNSVoluson SWIFT receives FDA clearance
30th Sep 20207:00 amRNSGE Healthcare launches new ultrasound AI software
21st Sep 20207:00 amRNSChange of Registered Office
18th Sep 20207:00 amRNSFDA filing submitted for second ScanNavAI software
16th Sep 20207:00 amRNSFormation of Nomination Committee
6th Aug 20207:00 amRNSHalf-year Report
3rd Aug 20207:00 amRNSNotice of Results
13th Jul 20207:00 amRNSTrading Update
18th Jun 202011:30 amRNSResult of AGM
18th May 20207:00 amRNSNotice of AGM and publication of Annual Report
7th May 20205:29 pmRNSHolding(s) in Company
7th May 202011:03 amRNSHolding(s) in Company
6th May 20209:36 amRNSDirector dealings
4th May 202011:27 amRNSResult of General Meeting & Total Voting Rights
24th Apr 20202:57 pmRNSGrant of Options
22nd Apr 20207:00 amRNSBodyWorks COVID-19 Ultrasound Simulator case study
17th Apr 20203:22 pmRNSPlacing to raise £5.2m and Notice of GM
3rd Apr 20207:00 amRNSNHS Nightingale ExCel Hospital
26th Mar 20207:00 amRNSFinal Results
25th Mar 20207:00 amRNSCOVID-19 update; COVID-19 training module launch
4th Mar 20207:00 amRNSISO13485 certification for medical devices
4th Mar 20207:00 amRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSNotice of Results
6th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
29th Jan 20207:00 amRNSMinisterial visit to Intelligent Ultrasound HQ
8th Jan 20207:00 amRNSTrading Update
26th Nov 20197:00 amRNSDirectorate Changes
25th Nov 20197:00 amRNSContingent Liability Update
17th Oct 20191:00 pmRNSAgreement with FUJIFILM SonoSite, Inc.
23rd Sep 20197:00 amRNSUltrasound AI database exceeds four million images
4th Sep 20197:00 amRNSClarification of change of holding
2nd Sep 201911:48 amRNSHolding(s) in Company
30th Aug 20196:17 pmRNSHolding(s) in Company
28th Aug 20195:16 pmRNSHolding(s) in Company
28th Aug 20199:12 amRNSDirector/PDMR Shareholding
27th Aug 201911:45 amRNSResult of General Meeting and Open Offer
8th Aug 20197:00 amRNSPlacing, Open Offer and Notice of General Meeting
31st Jul 20197:00 amRNSHalf-year Report
25th Jul 20197:00 amRNSCollaboration with National Imaging Academy Wales
10th Jul 20197:00 amRNSTrading update
4th Jul 20197:46 amRNSFirst OEM agreement for AI based imaging software
23rd May 20193:14 pmRNSResult of AGM
23rd May 20197:00 amRNSAGM Statement
16th May 20197:00 amRNSFirst live demonstration of ScanNav AnatomyGuide
30th Apr 20197:00 amRNSNotice of Annual General Meeting
28th Mar 20197:00 amRNSFinal Results
19th Feb 20197:00 amRNSNotice of Results
24th Jan 20197:00 amRNSInvestor presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.